Direct Noise Reduction in the Intensive Care Units (ICU) Using Earplugs and Noise Canceling Headphones
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01343095 |
Recruitment Status :
Terminated
(Loss of study staff)
First Posted : April 27, 2011
Results First Posted : December 20, 2017
Last Update Posted : September 12, 2018
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Delirium Sleep Fragmentation | Device: Foam Earplugs Device: Noise Canceling Headphones | Not Applicable |
Delirium is an acute confusional state defined by fluctuating mental status, inattention, and either disorganized thinking or an altered level of consciousness. Acute delirium is an increasingly recognized problem in intensive care units (ICUs) in the US and worldwide. ICU Delirium has been estimated to occur in as many as 50 to 80 percent of ICU patients. Delirium in the ICU has been associated with worsened clinical outcomes such as prolonged hospitalization and death [1-4]. Although noise has been shown to negatively influence sleep in the ICU, and sleep disturbance is a recognized contributor to ICU delirium[1-2, 4], there is no well-established link between ICU noise levels and the development of ICU delirium. Optimal strategies for the prevention and treatment of ICU delirium are yet to be defined, and this study will focus on a novel noise-reduction approach which has potential to impact both prevention and treatment [5-8]. Findings will be generalizable to other tertiary care medical intensive care units caring for adult patients.
Objectives Our multidisciplinary team will evaluate the safety and feasibility of direct noise reduction in the Wake Forest University Baptist Medical Center (WFUBMC) Medical Intensive Care Unit (MICU), and any effect on the incidence of ICU delirium.
Methods and Measures Design
- Forty-five (45) patients receiving mechanical ventilation will be randomized to receive either passive direct noise reduction (earplugs), both passive and active direct noise reduction (earplugs and noise-canceling headphones), or no direct noise reduction (usual practice).
- Ambient noise levels and the reduction in noise accomplished by direct noise reduction will be measured according to standardized audiometric techniques.
- Sleep structure, including amount of recovery sleep, will be measured over one night according to standardized polysomnographic (sleep study) techniques
- The incidence of delirium will be assessed as well as multiple other endpoints including but not limited to amount of psychoactive medication prescribed and amount of physical restraints required.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 8 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | A Randomized Controlled Trial of Direct Noise Reduction in the ICU Using Overnight Application of In-ear Earplugs or In-ear Earplugs Plus Noise-Canceling Headphones to Reduce the Incidence and Duration of ICU Delirium |
Study Start Date : | May 2011 |
Actual Primary Completion Date : | December 2014 |
Actual Study Completion Date : | June 2015 |
Arm | Intervention/treatment |
---|---|
No Intervention: Usual Care
Usual Care between 10pm-6am
|
|
Active Comparator: Earplugs
Application of foam earplugs from 10pm-6am nightly for seven nights or until ICU discharge.
|
Device: Foam Earplugs
Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer) |
Active Comparator: Earplugs and Headphones
Foam Earplugs and Noise canceling headphones applied from 10pm-6am nightly for 7 nights or until ICU discharge.
|
Device: Foam Earplugs
Standard Foam Earplugs applied from 10pm-6am nightly. (Sperian Technologies, manufacturer) Device: Noise Canceling Headphones Noise Canceling headphones applied over the ears between 10pm-6am nightly. Model is Bose QuietComfort 15, manufactured by Bose Technologies. |
- Days Free of Delirium or Coma [ Time Frame: During the Study Period (Study Days 0-7 while patients were in ICU) ]
- Noise Attenuation [ Time Frame: Overnight (10pm-6am) on study day 2 or 3. ]The reduction in noise experienced by the subject when using the study intervention.
- Sleep Efficiency and Architecture [ Time Frame: Overnight (10pm-6am) on study day 2 or 3 ]Staging of sleep with efficiency determined as a ratio of total sleep time/total study time.
- Amount of Sedative Use (Midazolam and Lorazepam) [ Time Frame: During the Study Period (Study Days 0-7) ]
- Amount of Analgesic Use [ Time Frame: During the Study Period (Study Days 0-7) ]Mean of analgesic daily use
- Amount of Sedative Use (Propofol and Demedetomidine ) [ Time Frame: During the Study Period (Study Days 0-7) ]Mean of sedative daily use (Propofol and Demedetomidine )
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adult patients who are admitted to our MICU for at least 24 hours with at least 72 hours' additional expected stay in ICU, and who are mechanically ventilated
Exclusion Criteria:
- severe to profound hearing loss
- baseline use of hearing aids
- eardrum perforation
- severe cerumen impaction
- head or oromaxillofacial trauma
- external ventricular drain or intracranial pressure monitoring devices
- comatose patients who are deemed by their attending physician as unlikely to awaken within 72 hours
- patient status as comfort-measures only
- any other contraindication to the use of earplugs or headphones
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01343095
United States, North Carolina | |
Wake Forest Baptist Medical Center | |
Winston-Salem, North Carolina, United States, 27157 |
Study Director: | Matthew C Miles, MD | Wake Forest University Health Sciences |
Responsible Party: | Wake Forest University |
ClinicalTrials.gov Identifier: | NCT01343095 |
Other Study ID Numbers: |
IRB00013140 |
First Posted: | April 27, 2011 Key Record Dates |
Results First Posted: | December 20, 2017 |
Last Update Posted: | September 12, 2018 |
Last Verified: | August 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | de-identified data was shared with another investigator as part of a review and meta-analysis |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
ICU Delirium Delirium Sleep Quality Sleep Efficiency |
ICU Noise Noise Reduction Earplugs Noise Canceling Headphones |
Delirium Sleep Deprivation Confusion Neurobehavioral Manifestations Neurologic Manifestations |
Nervous System Diseases Neurocognitive Disorders Mental Disorders Dyssomnias Sleep Wake Disorders |